Vice President, US Oncology Thoracic and GI Franchise Lead @ (January 2021 - January 2022)
Executive Director, Opdivo (nivolumab) Lung Cancer @ (January 2015 - January 2021)
Brand Lead Erbitux (cetuximab) - US Oncology Marketing @ (January 2015 - January 2015)
Chief of Staff, U.S. Commercial Oncology @ (January 2014 - January 2015)
Payer Marketing Director Hematology and Oncology - Sprycel (dasatinib) CML @ (January 2012 - January 2014)
Global Marketing Director - Yervoy (ipilimumab) Melanoma @ (January 2010 - January 2012)
Global Marketing Director - GI Portfolio Strategy @ (January 2008 - January 2010)
Global Brand Director Oncology @ (April 2006 - August 2008)
Brand Marketing Manager - US Marketing Taxotere (docetaxel) @ (March 2001 - April 2006)
eMarketing Manager @ (June 1994 - January 2001)
Dan Szeliga Education
CEDEP - Executive Development – Fontainebleau 2019-2020
watchung regional high school
Rutgers University
B.S. (Cook College; Rutgers College of Engineering)
Dan Szeliga Skills
Oncology
Pharmaceutical Industry
Global Marketing
Biotechnology
Market Access
Product Launch
Commercialization
Cross-functional Team Leadership
Sales Effectiveness
Urology
Marketing Strategy
Managed Care
Hematology
Clinical Development
Cross Functional Team
Online Marketing
Clinical Research
Healthcare
Digital Marketing
Strategic Planning
Marketing
Cross Functional Team Leadership
Social Media Marketing
Dan Szeliga Summary
Dan Szeliga, based in Pennington, NJ, US, is currently a SVP, Head of Commercial at RayzeBio. Dan Szeliga brings experience from previous roles at Mirati Therapeutics and Bristol-Myers Squibb. Dan Szeliga holds a 2019 - 2020 CEDEP - Executive Development – Fontainebleau. With a robust skill set that includes Oncology, Pharmaceutical Industry, Global Marketing, Biotechnology, Market Access and more. Dan Szeliga has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Dan Szeliga?
Find contact details for 700 million professionals.